how to manage tirzepatide side effects 18 Possible of (Mounjaro, Zepbound) The Zepbound Dossier : A

The SD of glucose was also evaluated by pooling 11 studies, which revealed an 8.19 (95% CI 4.78 to 11.61) drop with AID use (Figure S16)

Fielding R, et al

[1] [2] The potential cardioprotective mechanisms of certain GLP-1 receptor agonists may involve improvements in glycemic control, weight reduction, blood pressure lowering, and possibly other effects on vascular function, though the exact mechanisms continue to be studied

Patients also have access to ongoing education and a support community for additional guidance between consultations

These are rare, not everyday side effects, and here the two labels look almost identical